Intrapartum azithromycin to prevent maternal and neonatal sepsis and deaths: A systematic review with meta-analysis.

Published in: BJOG : an international journal of obstetrics and gynaecology (2023)

Intrapartum administration of azithromycin to the mother reduces maternal postpartum infections, including sepsis. Impact on maternal mortality remains undecided. Azithromycin does not reduce neonatal sepsis or mortality rates.

Keyphrases

septic shock
acute kidney injury
birth weight
intensive care unit
pregnancy outcomes
cardiovascular events
weight gain
coronary artery disease
body mass index